Jul 02 2024 73 mins 6
This episode features Paradromics CEO Matt Angle in a compelling discussion with Grayson Zulauf, CEO of Resonant Link; Alex Yeh, CTO and VP of R&D at Neuspera Medical; and Jacob Robinson, Founder and CEO of Motif Neurotech. They explore the latest advancements in neurotechnology, focusing on wireless power transfer, implantable devices, and brain-computer interfaces (BCIs). The conversation highlights transformative innovations in treating mental health conditions like major depressive disorder, OCD, and ADHD with less invasive wireless devices, enhancing patient care and acceptance. Personal stories and insights on market expansion and patient-friendly treatments are shared, along with valuable advice for investors on the potential of neurotechnology in improving overall mental health and medical care.
Guest Quote:
“The message that I would want to send is, there is a future in which we look at neurotechnologies no differently than we look at cardiac pacemakers.
These are life saving devices, in many cases less invasive than a device that goes in your heart. There's no reason why anybody wouldn't want to feel better. To be healthier mentally and just live a better quality of life. So that's what we're trying to enable” - Jacob Robinson
Show Notes:
*(00:00) Welcome to Neurotech Pub
*(00:46) Meet the Guests
*(02:45) Discussing Industry Competitors
*(09:54) Wireless Power Transfer in Medical Devices
*(16:38) Exploring Inductive and Magnetoelectric Power
*(27:35) Ultrasound in real-world devices
*(33:31) Patient Experience and Device Miniaturization
*(36:24) Designing for Patient Comfort and Practicality
*(38:20) Innovations in Power and Data Transmission
*(39:32) Miniaturization and Its Impact
*(41:12) Battery Technology in Medical Devices
*(43:19) Future of Implantable Batteries
*(45:16) Implanted Battery Companies Integer and Resonetics
*(46:31) Intermittent Stimulation and Therapy
*(49:28) Power Consumption in Future Implants
*(59:52) Data Transmission and Compression
*(01:05:42) Reflections on the Journey of Medical Innovation
*(01:08:36) Final Thoughts and Messages to Investors
Want More?
Follow Neurotech Pub on Twitter
